Range
- - -
Vol / Avg.
-/224.1K
Div / Yield
-
52 Wk
6.26 - 15.5
Mkt Cap
179.3M
Payout Ratio
-
Open
-
P/E
-
EPS
-1.08
Shares
19.4M
Outstanding
19.4M
Total Float
19.3M
Benzinga - Jun 9, 2021, 12:05PM
Benzinga - Jun 9, 2021, 7:34AM
Benzinga - Jun 9, 2021, 6:44AM
Benzinga - May 18, 2021, 7:41AM
Benzinga - May 18, 2021, 6:22AM
Benzinga - May 17, 2021, 8:20AM
Benzinga - May 17, 2021, 8:11AM
Benzinga - May 7, 2021, 8:35AM
Benzinga - May 7, 2021, 7:10AM
Benzinga - May 6, 2021, 5:45PM
Benzinga - Apr 16, 2021, 7:51AM
Benzinga - Apr 16, 2021, 6:37AM
Benzinga - Apr 8, 2021, 9:38AM
Benzinga - Apr 8, 2021, 7:04AM
load more
Sector: Health Care.Industry: Biotechnology
F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-01
REV
Q1 2021Est.ActualSurprise
EPS-1.160-1.080 0.0800
REV1.200M2.917M1.717M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
FSTXF-star Therapeutics-2.81%179.3M

F-star Therapeutics Frequently Asked Questions

Q

How do I buy F-star Therapeutics (FSTX) stock?

A

You can purchase shares of F-star Therapeutics (NASDAQ: FSTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are F-star Therapeutics's (FSTX) competitors?

A

Other companies in F-star Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Heat Biologics (NASDAQ:HTBX), Galectin Therapeutics (NASDAQ:GALT), Voyager Therapeutics (NASDAQ:VYGR) and T2 Biosystems (NASDAQ:TTOO).

Q

What is the target price for F-star Therapeutics (FSTX) stock?

A

The latest price target for F-star Therapeutics (NASDAQ: FSTX) was reported by B. Riley Securities on June 9, 2021. The analyst firm set a price target for 28.00 expecting FSTX to rise to within 12 months (a possible 202.38% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for F-star Therapeutics (FSTX)?

A

The stock price for F-star Therapeutics (NASDAQ: FSTX) is $9.26 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does F-star Therapeutics (FSTX) pay a dividend?

A

There are no upcoming dividends for F-star Therapeutics.

Q

When is F-star Therapeutics (NASDAQ:FSTX) reporting earnings?

A
F-star Therapeutics’s Q2 earnings are confirmed for after-market on August 1, 2021.
Q

Is F-star Therapeutics (FSTX) going to split?

A

There is no upcoming split for F-star Therapeutics.

Q

What sector and industry does F-star Therapeutics (FSTX) operate in?

A

F-star Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.